CST
RMD icon

Charles Schwab Trust’s ResMed RMD Stock Holding History

Charles Schwab Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Hold
1,590
– – 0.02% 151
2026
Q1 		$357K Sell
1,590
-56
-3% -$14K 0.02% 129
2025
Q4 		$396K Hold
1,646
– – 0.03% 130
2025
Q3 		$451K Hold
1,646
– – 0.03% 126
2025
Q2 		$425K Buy
+1,646
New +$393K 0.03% 130

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Charles Schwab Trust's RMD Position: Q2 2026 in Review

Charles Schwab Trust held its ResMed (RMD) position steady in Q2 2026 at 1,590 shares worth $310K. The position accounts for 0.02% of the portfolio, ranked #151.

Charles Schwab Trust first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $451K in Q3 2025. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Charles Schwab Trust held 1,590 shares of ResMed worth $310K as of Q2 2026.
  • Charles Schwab Trust left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.02% of Charles Schwab Trust's portfolio in Q2 2026, its #151 holding.
  • Charles Schwab Trust first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Charles Schwab Trust's ResMed position peaked at $451K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.